Replies to post #820116 on NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

I think your AI is getting dumber.

[Riley4]

ILT this sounds great and all but the MM’ don’t give a crap, t he’ll just keep shorting all they want cause they know there is no real enforcement, they don’t care if there are no authorized shares to short as they never have in the past. If trading here all stays the same until approved

[martyDg]

Okay guys, the “Joker”—I mean Prophet—now says “UPGRADED TO MID-APRIL,” straight from his crystal ball. This guy is the real deal—imagine being able to move the goalposts this many times, that’s actually impressive. At this point, he might even be better than that “Fitness doctor” who said we were in the labeling phase back in October last year. I believe you! Please keep up entertaining us! 

[QuantumRebel88]

Thanks ILT. I love the conviction that you have on your findings. Created a timeline so that I could see this in a more linear/visual manner. I have to say that the timing of all of this appears quite coordinated. I am crossing my fingers!

The NWBO "Golden Nugget" Timeline (March 25 – April 15)

Date
Event
ILT’s "Forensic" Interpretation
Mar 25–26
The Pilot Prep
The MHRA Innovation Pilot window closed. NWBO secured a final "Route B" manufacturing fast-track and fee waiver for the Sawston facility to align with new UK standards.
Mar 27 (Fri)
The LSE Refresh
The London ticker (0K95) updated to "Special Condition: Normal - Closed." This is viewed as the "Stabilization Guardrail" used by market makers to lock the 1.31 EUR price for the Sovereign transfer.
Mar 27 (Fri)
The Convoy Signal
Peer companies Oxford Biomedica and Autolus released major commercial updates, signaling that the UK’s biotech "Sovereign" infrastructure was officially ready to receive NWBO.
Mar 30 (Mon)
The "GZ" Response
NWBO Investor Relations claimed they "knew nothing" about the LSE. ILT argues this was a Legal Necessity (NDA silence) required to prevent "tipping" before the April 1st regulatory reset.
Mar 31 (Tue)
The NT 10-K
The Tactical Extension. NWBO filed a 12b-25 delay, citing "Advent UK vs. US GAAP reconciliation." This is the "Cloak" used to hide the final share count until the UK approval is public.
Apr 1 (Today)
The UK Reset
The £35,000 QALY threshold and 14.5% VPAG tax rate became law. The MHRA-NICE "Aligned Pathway" officially opened, allowing for simultaneous safety and price approval.
Apr 2–7
The FAD Window
Expected Event: NICE releases the Final Appraisal Document (FAD) or the MHRA grants Marketing Authorisation. This "de-risks" the science before the financial unmasking.
Apr 8–14
The Gamma Force
Expected Event: Brokerages trigger Forced Liquidations of short positions as the "20x Multiplier" (per Chiugray) on Mark-to-Market losses becomes unmanageable for underwater shorts.
Apr 15 (Wed)
The Pristine Ledger
The Grand Finale. NWBO files the full 10-K (Annual Report). The "Shadow" share count is legally revealed, confirming the 165M "Extraction" and the Sovereign deal.